The Australian Dementia Network (ADNeT) is disappointed with the decision by the Therapeutic Goods Administration (TGA) to reject the use of lecanemab in Australia. This decision denies Australians access to a therapy that has been shown to slow cognitive decline and is at odds with its approval in the United States, Japan, China, South Korea,...
Read more
You can follow us on Twitter and Facebook for more updates and announcements!
Read more
Australian Dementia Network Registry informs clinical practice, shapes policy and supports research: 2023 annual report The Australian Dementia Network (ADNeT) Registry released its 2023 Annual Report at a public webinar attended by people living with dementia and their families, clinicians, researchers, and policy makers. The ADNeT Registry captures data from a diverse group of Australians...
Read more

Welcome to the official website of the Australian Dementia Network (ADNeT).

Whether you are a researcher, a health professional, or a member of the public, we hope our website provides you with relevant information on our works, a suite of valuable tools and other resources, and news on the latest advancements in dementia diagnosis, prevention, treatment, and care.

Resources

PET Reading Training

As part of the education component of ADNeT, Director Professor Christopher Rowe has prepared two training videos (Part 1 and Part 2) to help imaging specialists interpret PET scans.
Memory and Cognition Clinic Guidelines

National Service Guidelines for Specialised Dementia and Cognitive Decline Assessment Services in Australia.
All Resources

ADNeT resources for the general public, consumers, researchers and clinicians.

ADNeT Partners

Supported By